Yes. The IG-SRT device and technique have been cleared by the U.S. Food and Drug Administration. In fact, the modern image-guided superficial radiotherapy machines received FDA clearance in 2015 after data and clinical studies demonstrated their safety and effectiveness. This means the treatment met the FDA’s standards for use in treating skin cancers. Since that time, IG-SRT has been adopted in dermatology practices and cancer centers across the country. In addition to FDA clearance, IG-SRT is supported by peer-reviewed research and has coverage from Medicare and insurers, reflecting its acceptance in mainstream medical practice. So, patients can be confident that IG-SRT is an established, vetted treatment – not an experimental or unproven therapy.
Category:
IG-SRT



